Home > Analytics > SUN PHARMACEUTICAL INDUSTRIES

SUN PHARMACEUTICAL INDUSTRIES
Intrinsic Value | Fundamental Analysis

BOM : 524715     NSE : SUNPHARMA    
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Good [Stock is Cheap]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Sep 27,2022
Price(EOD): ₹ 896.90
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: ₹ 215,193.22 Cr
Value of ₹ 1 Lac invested in SUN PHARMACEUTICAL INDUSTRIES
on Sep 27,2017 (price: ₹ 494.95)

₹ 1 L

₹ 1.81 L

1W : -0.9% 1M : 2% 1Y : 16.6%
COMMUNITY POLL
for SUN PHARMACEUTICAL INDUSTRIES
Please provide your vote to see the results
SUN PHARMACEUTICAL INDUSTRIES is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Top Undervalued Large Cap Stocks
Best Quarterly Growth Large Cap Stocks
Industry Peers & Returns1W1M1Y
SUN PHARMACEUTICAL INDUSTRIES -0.9% 2% 16.6%
DIVIS LABORATORIES 2.9% 2.5% -29.2%
DR REDDYS LABORATORIES 0.8% -1% -14.9%
CIPLA 3% 7.9% 10.1%
GLAND PHARMA -5% -13.5% -47.2%
PIRAMAL ENTERPRISES -8.3% -55.7% -68%
CADILA HEALTHCARE -1.6% -5.7% -37.2%
TORRENT PHARMACEUTICALS 2.2% -0.9% -2.4%
ALKEM LABORATORIES 1.5% 13.3% -17%

FUNDAMENTAL ANALYSIS OF SUN PHARMACEUTICAL INDUSTRIES

 
Fundamentals Score
[ Q(TTM): Jun2022, Y: Mar2022
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]

Insights 💡 SUNPHARMA is one of the top 18% companies with good fundamentals ! Discover More →

VALUATION OF SUN PHARMACEUTICAL INDUSTRIES

 
Valuation Score
[As on : Sep 27,2022 ]

Ratio Consolidated
P/E
P/B
P/S
52.58
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 4,093.02 Cr
[Latest Qtr - Jun2022 - Consolidated Results ]

4.48
P/B Calculated based on Book Value of Rs 48,011.20 Cr
[Latest Year - Mar2022 - Consolidated Results ]

5.42
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 39,697.50 Cr
[Latest Qtr - Jun2022 - Consolidated Results ]

Financial Ratios →

Insights 💡 SUNPHARMA is one of the potential top 17% undervalued companies ! Discover More →

FAIR VALUE OF SUN PHARMACEUTICAL INDUSTRIES

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
17%
-24%
-26%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF SUN PHARMACEUTICAL INDUSTRIES



SUN PHARMACEUTICAL INDUSTRIES vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF SUN PHARMACEUTICAL INDUSTRIES

Year Debt/Equity ratio
Standalone Consolidated
2022
2021
2020
Avg_3yrs
0.2
0.26
0.26
0.24
0.02
0.08
0.18
0.09
[Last Annual Data : Mar2022]
Financial Ratios →

PLEDGED PROMOTER SHARES OF SUN PHARMACEUTICAL INDUSTRIES

Pledged Promoter Shares
4.04 %
As on : Jun2022

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF SUN PHARMACEUTICAL INDUSTRIES

Consolidated Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
13.92%
25.67%
210.08%
194.31%
10.73%
-0.09%
26.64%
48.78%
QtrlyTrend
6
Latest Qtr: Jun2022
Quarterly Result Analysis →


SUN PHARMACEUTICAL INDUSTRIES related INDICES

BSE Indices1W1M1Y
S&P BSE HEALTHCARE -0.3% -0.9% -14%
S&P BSE LOW VOLATILITY -1.5% -3.1% -8.9%
S&P BSE 500 SHARIAH -2% -3.1% -6.3%
MFG -2.5% -2.7% 1.4%
S&P BSE SENSEX -3.4% -3.3% -3.2%
NSE Indices1W1M1Y
NIFTY HEALTHCARE 1.3% -0.6% -12.4%
NIFTY GROWTH SECTOR 15 1.2% 11.6% 9.1%
NIFTY PHARMA 0.9% -1.3% -12.6%
NIFTY 100 ALPHA 30 -1.3% 4.2% 4.5%
NIFTY ALPHA LOW-VOLATILTY 30 -1.8% -0.1% -7%

You may also like the below Video Courses


FAQ about SUN PHARMACEUTICAL INDUSTRIES


Is SUN PHARMACEUTICAL INDUSTRIES good for long term investment?

As on Sep 27,2022, the Fundamentals of SUN PHARMACEUTICAL INDUSTRIES look Strong and hence it may be good for long term investment! See Financial Performance of SUN PHARMACEUTICAL INDUSTRIES . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is SUN PHARMACEUTICAL INDUSTRIES UnderValued or OverValued?

As on Sep 27,2022, SUN PHARMACEUTICAL INDUSTRIES is Under Valued based on the estimates of intrinsic value and hence may be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of SUN PHARMACEUTICAL INDUSTRIES ?

As on Sep 27,2022, the Intrinsic Value of SUN PHARMACEUTICAL INDUSTRIES is Rs. 1,177.24 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 769.50
Fair Value [Median EV / Sales Model] : Rs. 1,177.24
Fair Value [Median Price / Sales Model] : Rs. 1,217.75
Estimated Median Fair Value of SUN PHARMACEUTICAL INDUSTRIES : Rs. 1,177.24

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is SUN PHARMACEUTICAL INDUSTRIES trading at a Premium or Discount?

As on Sep 27,2022, SUN PHARMACEUTICAL INDUSTRIES is trading at a Discount of -24% based on the estimates of Median Intrinsic Value!

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].